![]()
09.07.20151719
The Clopidogrel in High-risk patients with Acute Non-disabling Cerebrovascular Events (CHANCE) trial showed that the combined treatment of clopidogrel and aspirin decreases the 90-day risk of stroke without increasing hemorrhage in comparison with aspirin alone, but provided insufficient data to establish whether the benefit persisted over a longer period of time beyond the trial termination.
![]()
08.07.20151477
Adding an extra 18 months of warfarin therapy to the standard 6 months of anticoagulation delays the recurrence of venous thrombosis in patients who have a first episode of unprovoked pulmonary embolism.
![]()
07.07.20151658
The FDA has approved a first-in-class angiotensin receptor-neprilysin inhibitor for the reduction of CV death and HF-related hospitalization among patients with HF and reduced ejection fraction, according to a press release.
![]()
06.07.20151460
Traditionally venous and arterial thrombosis has been viewed as two separate pathophysiological and clinical entities.
![]()
03.07.20151746
Older adults with a history of coronary heart disease have a substantially lower cortical volumetric bone mineral density at the distal radius, putting them at risk for fracture, according to research in Osteoporosis International.
![]()
02.07.20151572
There are few prospective data available for establishing a standard diuretic administration regimen for patients with acute decompensated heart failure (ADHF).
![]()
01.07.20152594
The antithrombotic management of patients on oral anticoagulation (OAC), with either warfarin or non-vitamin K-antagonist oral anticoagulants (NOACs), undergoing percutaneous coronary intervention with stent (PCI-S) has been recently addressed in a joint European consensus document.
